Cardiac fibrogenesis following infarction in mice with deletion of inducible nitric oxide synthase

American Journal of the Medical Sciences

Volumn 335, Issue 6, 2008, Pages 431-438

  Lu, L I ^a   Chen, Sue S I ^a   Hassid, Aviv ^a   Sun, Y A O ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cardiac fibrosis; Mice; Myocardial infarction; Nitric oxide

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MESSENGER RNA; NITRIC OXIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME SYNTHESIS; HEART INFARCTION; HEART MUSCLE FIBROSIS; KNOCKOUT MOUSE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; FIBROSIS; GENE DELETION; GENE EXPRESSION; GENETICS; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FIBROSIS; GENE DELETION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 47749129216     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181571f97     Document Type: Article

References (22)

1. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003;08:1395-403.
2. Ertl G, Frantz S. Healing after myocardial infarction. Car-diovasc Res 2005;66:22-32.
3. Anversa P, Li P, Zhang X. Ischemic myocardial injury and ventricular remodeling. Cardiovasc Res 1993;27:145-57.
4. Papapetropoulos A, Rudic RD, Sessa WC. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 1999;43:509-20.
5. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999;55:1015-28.
6. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999;43:521-31.
7. Takimoto Y, Aoyama T, Keyamura R. Differential expression of three types of nitric oxide synthase in both infarcted and non-infarcted left ventricles after myocardial infarction in the rat. Int J Cardiol 2000;l76:135-45.
8. Bing RJ, Suzuki H. Myocardial infarction and nitric oxide. Mol Cell Biochem 1996;160-161:303-6.
9. Liu YH, Carretero OA, Cingolani OH. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol 2005;289:H2616-H2623.
10. Marfella R, Di Filippo C, Esposito K. Absence ofinducible nitric oxide synthase reduces myocardial damage during ischemia reperfusion in streptozotocin-induced hyperglyce-mic mice. Diabetes 2004;53:454-62.
11. Feng Q, Lu X, Jones DL. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 2001;104:700-4.
12. Desmouliere A, Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Richard AF, editor. The molecular and cellular biology of wound repair. New York, NY: Plenum Press; 1996. p. 391-423.
13. Sun Y, Weber KT. Angiotensin converting enzyme and myo-fibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996;28:851-8.
14. Sun Y, Zhang JQ, Zhang J. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol 1998;30:1559-69.
15. Zhao W, Ahokas RA, Sun Y. ANG Il-induced cardiac molecular and cellular events: role of aldosterone. Am J Physiol Heart Circ Physiol 2006;291:H336-H343.
16. Sun Y, Zhang JQ, Zhang J. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 2000; 135:316-23.
17. Sun Y, Ratjaska A, Weber KT. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J Lab Clin Med 1995;126:95-101.
18. Youn TJ, Kim HS, Oh BH. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects ofangio-tensin converting enzyme inhibition and angiotensin II type 1 receptor blockade. Basic Res Cardiol 1999;94:246-53.
19. Yue P, Massie BM, Simpson PC. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 1998;275:H250-H258.
20. Yano T, Miura T, Ikeda Y. Intracardiac fibroblasts, but not bone marrow derived cells, are the origin ofmyofibroblasts in myocardial infarct repair. Cardiovasc Pathol 2005;14:241-6.
21. Ronty MJ, Leivonen SK, Hinz B. Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation. J Invest Derma-tol 2006;126:2387-96.
22. Kassiri Z, Khokha R. Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost 2005;93:212-9.